Carbon Monoxide (CO)

Pollutants - Gases - CO.jpg

MONITORING OPTIONSPRICINGABOUT CO
MONITORING OPTIONS

AirQuality Limited can offer a variety of monitoring options for the monitoring of carbon monoxide including:

  • CO Direct-reading instrumental method
  • CO Electrochemical Sensor

More detail on each of these options is shown below:

CO Direct reading Instrumental Method

The direct reading carbon monoxide analyser is a reference standard instrument which can meet the requirements of AS 3580.7.1-2011: Determination of carbon monoxide – Direct-reading instrumental method. The correct operation of this instrument requires a temperature controlled enclosure.

CO Electrochemical Sensor
The AirQuality Gasmote-CO electrochemical sensor uses advanced electrochemical technologies in combination with data-logging, communications and global positioning systems

  • Capable of high quality indicative CO measurement
  • Continuous measurement, automated data up-load

PRICING

Pricing is dependent upon:

  • The length of time you wish to monitor for
  • The type of equipment you wish to use
  • Whether you wish to purchase or rent the monitoring instrumentation
  • The level of data validation and reporting
  • Whether an instrument enclosure is required
  • Whether mains or solar powered options are required
  • Whether wind speed and direction also need to be measured

Our clients tell us that we offer very competitive quotes for both the supply and operation of these instruments.

Contact us today for an obligation free quote!

ABOUT CO

The formation of COHb reduces the amount of haemoglobin available for the transportation of oxygen around the body. This can impact on the brain, nervous tissues, heart muscle and other specialised tissues that require large amounts of oxygen to function. As a result of oxygen deprivation, these organs and tissues may suffer temporary or permanent damage.

Those most susceptible to the health effects of ambient air exposure to CO include those with ischaemic heart disease, other forms of cardiac disease including cyanotic heart disease, hypoxaemic lung disease, cerebrovascular disease, peripheral vascular disease, those with anaemia and haemoglobin abnormalities, children, and developing foeti.

Dennison (2002) provides a comprehensive summary of the literature on health effects of carbon monoxide. This indicates the results of toxicological studies and the consequent evaluation of the lowest observed adverse effect levels (LOAEL) and no observed adverse effect levels (NOAEL) (Table 2.1) as well as recent epidemiological studies, which suggest that effects may occur at concentrations lower than indicated by toxicology.